Core Scientific (CORZ) stock
NASDAQ
As of the Nov 13, 2026 close (U.S. Eastern)
Events and reference metrics · 1
- Market cap
- $4.64B
- As of Nov 13, 2026
- P/E
- -42.94x
- Trailing twelve months
- P/B
- Not available
- Latest reported equity
- P/S
- 7.85x
- Trailing twelve months
- ROE
- Not available
- Trailing twelve months
- Dividend yield
- Not available
- Latest fiscal-year dividends
Multiples use the price as of Nov 13, 2026 and may differ from the current price.
- Market cap
- $4.64B
- As of Nov 13, 2026
- P/E
- -42.94x
- Trailing twelve months
- P/B
- Not available
- Latest reported equity
- P/S
- 7.85x
- Trailing twelve months
- ROE
- Not available
- Trailing twelve months
- Dividend yield
- Not available
- Latest fiscal-year dividends
Multiples use the price as of Nov 13, 2026 and may differ from the current price.
Compares the share price with the company's earnings, net assets and sales. Check trading status and financial notes separately.
Price date for the multiples · Nov 13, 2026 · Financial period · Trailing twelve months
P/E and P/S use the latest four quarters where available · P/B uses the latest equity · Computed in-house by ChickenStock
P/E
-42.94x
Net loss — not comparable
P/B
—
P/S
7.85x
Earnings and dividend metrics▾
Earnings
EPS
-$0.34
Earnings per share
BPS
—
Book value per share
ROE
—
Return on equity
- EPS — what one share earned over the last four quarters. The company is currently loss-making, at $0.34 per share.
ⓘ What are these valuation metrics?▾
P/E = share price ÷ earnings per share (EPS)
P/B = share price ÷ book value per share (BPS)
P/S = share price ÷ sales per share
P/E shows how many times annual earnings per share the price is; not all earnings are paid to shareholders. P/B compares the price with net assets, and P/S with sales.
Higher or lower is not good or bad by itself. Typical levels differ by industry; read P/B alongside ROE and P/S alongside margins.
ChickenStock computes these from SEC financial filings: net income and revenue are summed over the latest four quarters, and equity is the latest reported balance.
A negative P/E means a net loss. Reference information only, not a recommendation to buy or sell.
Latest earnings
SEC filingsJul–Sep 2026(FY2026 Q3)
Revenue increased 187.7% from the same period a year earlier.
Key reported figures come first. Select one to see the same quarter across three years.
Revenue · same quarter, three years
Year-ago quarter $81M+187.7%
$95M
Jul–Sep '24
$81M
Jul–Sep '25
$233M
Jul–Sep '26
The next earnings date has not been confirmed yet.
ⓘ Notes on these figures▾
- Results for Jul–Sep 2026 are from the 10-Q submitted to SEC EDGAR on Nov 5, 2026.
- Earnings per share increased from a year earlier. The year-ago value was zero or negative, so no percentage change is shown.
- Revenue increased 187.7% from the same quarter a year earlier.
- Operating income increased from a year earlier. The year-ago value was zero or negative, so no percentage change is shown.
- Net income increased from a year earlier. The year-ago value was zero or negative, so no percentage change is shown.
Filed Nov 5, 2026 · 10-Q · SEC EDGAR
Reported results are from SEC EDGAR filings. Reference information only, not investment advice.
Insider transactions
Recent Form 4 filings grouped by person, date and transaction type.
- Rozov YadinDirector · Nov 11, 2026Option exercise (expiring)30,000 shares · $204KAvg. price $6.81484,162 shares held after
- DUCHENE TODD MSee remarks · Nov 9, 2026Open-market sale10,000 shares · $125KAvg. price $12.4548
Show 2 price lots
- 7,900 shares × $12.3897$98K
- 2,100 shares × $12.6999$27K
- DUCHENE TODD MSee remarks · Nov 2, 2026Open-market sale10,000 shares · $128KAvg. price $12.7832
Show 2 price lots
- 9,900 shares × $12.7773$126K
- 100 shares × $13.37$1K
- DUCHENE TODD MSee remarks · Oct 26, 2026Open-market sale10,000 shares · $136KAvg. price $13.5594
Show 2 price lots
- 5,500 shares × $13.8$76K
- 4,500 shares × $13.2653$60K
- DUCHENE TODD MSee remarks · Oct 19, 2026Open-market sale10,000 shares · $139KAvg. price $13.87441,143,286 shares held after
- Sullivan Adam TaylorChief Executive Officer · Oct 16, 2026Shares withheld for taxes21,839 shares · $316KAvg. price $14.4554,391,079 shares held after
- DUCHENE TODD MSee remarks · Oct 16, 2026Shares withheld for taxes6,382 shares · $92KAvg. price $14.4551,153,286 shares held after
- DUCHENE TODD MSee remarks · Oct 12, 2026Open-market sale10,000 shares · $151KAvg. price $15.1161,159,668 shares held after
- DUCHENE TODD MSee remarks · Oct 5, 2026Open-market sale10,000 shares · $163KAvg. price $16.30561,169,668 shares held after
- Sullivan Adam TaylorChief Executive Officer · Oct 1, 2026Shares withheld for taxes23,508 shares · $376KAvg. price $15.984,412,918 shares held after
- DUCHENE TODD MSee remarks · Oct 1, 2026Shares withheld for taxes8,228 shares · $131KAvg. price $15.981,179,668 shares held after
- DUCHENE TODD MSee remarks · Sep 28, 2026Open-market sale10,000 shares · $168KAvg. price $16.75861,187,896 shares held after
- DUCHENE TODD MSee remarks · Sep 21, 2026Open-market sale10,000 shares · $184KAvg. price $18.37461,197,896 shares held after
- Weiss Eric StantonDirector · Sep 15, 2026Open-market purchase6,000 shares · $98KAvg. price $16.33265,262 shares held after
- DUCHENE TODD MSee remarks · Sep 14, 2026Open-market sale10,000 shares · $171KAvg. price $17.13621,207,896 shares held after
- DUCHENE TODD MSee remarks · Sep 8, 2026Open-market sale10,000 shares · $187KAvg. price $18.67351,217,896 shares held after
- DUCHENE TODD MSee remarks · Aug 31, 2026Open-market sale10,000 shares · $162KAvg. price $16.2341,927,896 shares held after
- DUCHENE TODD MSee remarks · Aug 24, 2026Open-market sale10,000 shares · $174KAvg. price $17.44931,937,896 shares held after
- CRAIN ELIZABETHDirector · Aug 20, 2026Open-market purchase6,000 shares · $110KAvg. price $18.332471,348 shares held after
- Weiss Eric StantonDirector · Aug 18, 2026Open-market purchase7,000 shares · $134KAvg. price $19.194259,262 shares held after
- DUCHENE TODD MSee remarks · Aug 17, 2026Open-market sale10,000 shares · $201KAvg. price $20.09741,959,101 shares held after
- DUCHENE TODD MSee remarks · Aug 17, 2026Shares withheld for taxes11,205 shares · $226KAvg. price $20.131,947,896 shares held after
- DUCHENE TODD MSee remarks · Aug 10, 2026Open-market sale10,000 shares · $200KAvg. price $19.9735
Show 2 price lots
- 9,000 shares × $19.8986$179K
- 1,000 shares × $20.648$21K
- DUCHENE TODD MSee remarks · Aug 3, 2026Open-market sale10,000 shares · $222KAvg. price $22.234
Show 3 price lots
- 7,500 shares × $22.6166$170K
- 1,500 shares × $21.55$32K
- 1,000 shares × $20.3903$20K
- Adams MarkDirector · Jul 30, 2026Grant or award27,594 shares · $0Avg. price $027,594 shares held after
- DUCHENE TODD MSee remarks · Jul 27, 2026Open-market sale10,000 shares · $209KAvg. price $20.9476
Show 3 price lots
- 8,300 shares × $20.7469$172K
- 1,600 shares × $21.8925$35K
- 100 shares × $22.49$2K
- DUCHENE TODD MSee remarks · Jul 20, 2026Open-market sale10,000 shares · $223KAvg. price $22.29951,999,101 shares held after
- Sullivan Adam TaylorChief Executive Officer · Jul 16, 2026Shares withheld for taxes15,584 shares · $354KAvg. price $22.724,436,426 shares held after
- DUCHENE TODD MSee remarks · Jul 16, 2026Shares withheld for taxes4,325 shares · $98KAvg. price $22.722,009,101 shares held after
Only transactions reported on SEC Form 4 are shown. A sale may follow a pre-arranged 10b5-1 plan, and items such as option exercises or shares withheld for taxes are not open-market trades.
Recent SEC filings
40 filingsFilings submitted to the U.S. Securities and Exchange Commission (EDGAR). Dates are SEC filing dates (U.S. Eastern). Form and item names are the official SEC titles. The Earnings and Risk tags come directly from form types and item codes; they are not written by AI. Insider ownership reports (Forms 3, 4 and 5) are excluded.
Company overview
Expand ▾
Core Scientific (CORZ) stock information
NASDAQ
Core Scientific (CORZ) is listed on NASDAQ. Its market capitalization is about $4.6B. On trailing-twelve-month earnings the P/E ratio is -42.94. These figures are computed in-house from official filings and are reference information only.
Core Scientific — frequently asked questions
- What is the P/E ratio of Core Scientific (CORZ)?
- On a trailing-twelve-month basis, CORZ trades at a P/E ratio of -42.94. It is calculated as market capitalization divided by net income attributable to controlling interests, using official filings. Reference information only.
- What is the market capitalization of Core Scientific?
- CORZ has a market capitalization of about $4.6B. The figure moves with the share price and is refreshed each trading day.
- Is this page investment advice?
- No. Every figure on this page is factual reference information compiled from public filings. It is not investment advice, not a price forecast and not a recommendation to buy or sell. Investment decisions rest with the user.
All metrics, scores, and content provided by ChickenStock are reference information derived from market data. They are not investment advice or a solicitation to trade. Investment decisions and their consequences rest with the user.